Sağlık Bakanı Prof Dr. Kemal Memişoğlu 'DHA Haber Merkezi'nin konuğu oldu
Summary
Share this article:
Related Articles
Taking another big step forward!
Today, as TCT, we had the pleasure of hosting the CEO and CTO of AbClon. Significant progress was made towards finalizing an MOU (Memorandum of Understanding) to strengthen our collaboration. As part of the visit, we also explored TÜBİTAK Medibiyo and Biruni University to discuss potential joint projects in cell therapy and biotechnology. This partnership with AbClon marks a critical milestone for bringing international opportunities in CAR-T cell therapy and gene therapies to Turkey. Our aim is to position our country at the forefront of biotechnology innovation and support local production initiatives. 🤝 Stay tuned for updates on our new collaborations and projects!
Driving Biotechnology Innovation in Turkey Through Strategic Collaboration with Cytiva
We welcomed the Cytiva Global Fast Trak team and Genomic Medicine team to Turkey for discussions on transformative technology transfer projects in collaboration with TCT. As part of this initiative, we visited Biruni University's Rectorate and TÜBİTAK Medibiyo to explore potential collaborations and evaluate key hubs for cell and gene therapy innovation. These discussions are paving the way for critical developments, with goals secured through strategic 3-way NDA agreements. This collaboration will enable us to bring cutting-edge technology and expertise to Turkey, reinforcing our commitment to localizing advanced therapies and creating a robust biotechnology ecosystem.
Inspiring visit to Koç University Hospital!
We had the privilege of visiting the Clinical Trials Unit and meeting Prof. Dr. Müjdat Zeybel. Koç University’s research capabilities are paving the way for innovation in advanced therapies. Excited for future collaborations to drive healthcare innovation in Turkey!